Overview

A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies

Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
The Purpose of this study is to determine if one allergy medication (0.15% azelastine hydrochloride) is more effective than Placebo alone.
Phase:
Phase 3
Details
Lead Sponsor:
Meda Pharmaceuticals
Treatments:
Azelastine